• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

It’s Steady as She Goes in Employer-Based Health Insurance

MHE PublicationMHE December 2021
Volume 31
Issue 12

The COVID-19 pandemic has disrupted healthcare and many parts of the U.S. economy, but employer-based health insurance?

The COVID-19 pandemic has disrupted healthcare and many parts of the U.S. economy, but employer-based health insurance? Largely unruffled, according to results of the Kaiser Family Foundation’s annual survey of employer health benefits.

The average annual premium for single and family coverage increased by 4% from 2020 to 2021, the same percentage increase as the year before, according to the survey. Covered workers shouldered 17% of the premium for single coverage and 28% for family coverage, similar to the worker share in 2020. The steadiness of the increase does not negate how fast premiums have risen: According to Kaiser, the average premium for family coverage has gone up 22% since 2016, twice the rate of inflation during that period.

The proportion of employers who offered coverage (59%) and the proportion of employees who enrolled in plans offered by their employers (62%) also saw little change between 2020 and 2021.

The broad outlines of the survey may suggest the gelling of a status quo for employer-based health benefits, but that does not mean there haven’t been notable shifts and adjustments. For example, the Kaiser survey found that the proportion of large firms offering biometric screening — checks of cholesterol levels, blood pressure and body mass index — is decreasing, from 50% in 2020 to 38% in 2021.

Wellness programs have, not surprisingly, gone digital and remote. The survey respondents indicated that 21% of the programs added a digital offering in 2021 and 34% reported tweaking their programs to accommodate people working at home.

And, of course, telemedicine is ascendant. Nearly all (95%) of the employers with 50 or more employees offered telemedicine in 2021, which the Kaiser survey defined as telecommunications with a provider in a different location (email and web-based videos did not count). That’s up from 85% in 2020.

The survey also revealed an interesting swing to “level-funded” plans among small employers that are self-insured. As explained by the Kaiser researchers who conducted the survey, level-funded plans bundled self-funding with extensive stop-loss insurance. The companies that sell the coverage charge a monthly fee (as the Kaiser researchers point out, it resembles a premium) that includes a percentage of the expected cost of the provision of the healthcare benefits, a premium for stop-loss coverage and an administrative fee.

The plan administrator, often an insurer, can consider the health status of the workforce, so level-funding can be a good deal for companies with employees who are young and, on average, healthy. But level-funding, because it is a form of self-insurance, escapes state premium taxes and state-mandated benefits. The Kaiser researchers reported that the survey showed a steep increase in the share of small firms with level-funded plans, from 13% in 2020 to 42% in 2021.

The Kaiser survey was conducted from mid-January 2021 through July. Representatives of 1,686 firms filled out the survey. Kaiser researchers reported the findings in Health Affairs in November.

Related Videos
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Video 1 - "The Influence of Social Determinants of Health on Diabetes Care and Outcomes"
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 4 - "Enhancing Patient Understanding and Treatment Adherence"
Video 2 - "Overview of Treatments for Atopic Dermatitis"
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Related Content
© 2024 MJH Life Sciences

All rights reserved.